Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
August 13, 2018 | Johnson & Johnson News
7 Questions for Alex Gorsky About Johnson & Johnson's Groundbreaking Work in South Africa
Johnson & Johnson CEO Alex Gorsky talks about the company's work in South Africa, including the dapivirine ring partnership. More »
July 24, 2018 | Crowd360
Creating Demand and OPTIONS for HIV Prevention
Ruth Nahurira held up a dapivirine vaginal ring as she spoke about her own experience with a dapivirine ring trial in Uganda at an AIDS 2018 pre-conference session. More »
June 08, 2018 | PSI Impact blog
Bringing Care to the Front Door
Innovative solutions including the dapivirine ring could shift control directly to health consumers’ hands for greater health outcomes. More »
May 25, 2018 | USAID on Medium
15 Years of the President’s Emergency Plan for AIDS Relief (PEPFAR)
USAID Administrator Mark Green on key steps PEPFAR has taken toward an AIDS-free world, including investments in microbicides research. More »
May 25, 2018 | Positively Aware
Vaginal ring shown effective
The interim HOPE results provide a promising picture of what could be another HIV prevention option, particularly for vulnerable women who may not have access to other prevention methods. More »